Recipient Class Drug means the Recipient Study Drug and any oncolytic virus derived from a potent herpes simplex virus strain expressing gibbon ape leukemia virus glycoprotein and eliciting anti-tumor activity.
Recipient Class Drug means the Recipient Study Drug and any other TLR-9 Agonist.
Recipient Class Drug means the Recipient Study Drug and any other TLR-9 Agonist. “Recipient Indemnitees” shall have the meaning set forth in Section 11.1.
More Definitions of Recipient Class Drug
Recipient Class Drug means (i) the Recipient Study Drug, and (ii) any other small molecule antagonist that is designed to and does selectively bind to and inhibit VEGF and Tyro/Axl/Mer in a physiologically meaningful manner comparable to the Recipient Study Drug.
Recipient Class Drug means (i) the Recipient Study Drug, and (ii) any other small molecule antagonist that is designed to and does selectively bind to and inhibit VEGF and Tyro/Axl/Mer in a physiologically meaningful manner comparable to the Recipient Study Drug .